Enantiomerically pure a-amino acids are compounds of primary interest for the fine chemical, pharmaceutical, and agrochemicals ectors.A mino acid oxidases are usedf or resolving d,l-amino acids in biocatalysis. We recently demonstrated that lamino acid deaminase from Proteus myxofaciens (PmaLAAD) showsp eculiar features for biotechnologicala pplications,s uch as ah igh production level as soluble protein in Escherichia coli and as table binding with the flavin cofactor.S ince l-amino acid deaminases are membrane-bound enzymes,p revious applications were mainly based on the use of cellbased methods.N ow,t aking advantage of the broad substrate specificity of PmaLAAD, an umber of natural and synthetic l-amino acids were fully converted by the purified enzyme into the corresponding aketo acids:t he fastest conversion was obtained for 4nitrophenylalanine.A nalogously,s tarting from race-mic solutions,t he full resolution (ee > 99%) was also achieved. Notably, d,l-1-naphthylalanine was resolved either into the d-o rt he l-enantiomer by using PmaLAADo rt he d-aminoa cid oxidase variant having ag lycine at position 213, respectively, and was fully deracemized when the two enzymes were used jointly.M oreover, the complete stereoinversion of l-4-nitrophenylalaninew as achieved using PmaLAADa nd as mall molar excesso fb orane tertbutylamine complex. Taken together, recombinant PmaLAADr epresents an l-specific amino acid deaminase suitablef or producing the pure enantiomers of several natural and synthetic amino acids or the corresponding keto acids,c ompounds of biotechnologicalo rp harmaceutical relevance.